Potential Applications of Plant Biotechnology against SARS-CoV-2.
作者： Teresa Capell , Richard M. Twyman , Victoria Armario-Najera , Julian K.-C. Ma , Stefan Schillberg
DOI: 10.1016/J.TPLANTS.2020.04.009
关键词:
摘要: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel responsible for an ongoing human pandemic (COVID-19). There massive international effort underway to develop diagnostic reagents, vaccines, and antiviral drugs in bid slow down the spread of disease save lives. One part that involves research community working with plants, bringing researchers from all over world together commercial enterprises achieve rapid supply protein antigens antibodies kits, scalable production systems emergency manufacturing vaccines drugs. Here, we look at some ways which plants can are being used fight against COVID-19.
sci-hub.se 参考文章(58)
Tsafrir S. Mor, Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story Biotechnology Letters. ,vol. 37, pp. 2147- 2150 ,(2015) , 10.1007/S10529-015-1908-Z
Julian K-C. Ma, Pascal M. W. Drake, Paul Christou, The production of recombinant pharmaceutical proteins in plants. Nature Reviews Genetics. ,vol. 4, pp. 794- 805 ,(2003) , 10.1038/NRG1177
Barry R. O'Keefe, Barbara Giomarelli, Dale L. Barnard, Shilpa R. Shenoy, Paul K. S. Chan, James B. McMahon, Kenneth E. Palmer, Brian W. Barnett, David K. Meyerholz, Christine L. Wohlford-Lenane, Paul B. McCray, Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae Journal of Virology. ,vol. 84, pp. 2511- 2521 ,(2010) , 10.1128/JVI.02322-09
Lanying Du, Yuxian He, Yusen Zhou, Shuwen Liu, Bo-Jian Zheng, Shibo Jiang, The spike protein of SARS-CoV — a target for vaccine and therapeutic development Nature Reviews Microbiology. ,vol. 7, pp. 226- 236 ,(2009) , 10.1038/NRMICRO2090
Julian K.-C. Ma, Ban Y. Hikmat, Keith Wycoff, Nicholas D. Vine, Daniel Chargelegue, Lloyd Yu, Mich B. Hein, Thomas Lehner, Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Medicine. ,vol. 4, pp. 601- 606 ,(1998) , 10.1038/NM0598-601
Woonsung Na, Nanuri Park, Minju Yeom, Daesub Song, Ebola outbreak in Western Africa 2014: what is going on with Ebola virus? Clinical and Experimental Vaccine Research. ,vol. 4, pp. 17- 22 ,(2015) , 10.7774/CEVR.2015.4.1.17
E. Vamvaka, R.M. Twyman, P. Christou, T. Capell, Can plant biotechnology help break the HIV-malaria link? Biotechnology Advances. ,vol. 32, pp. 575- 582 ,(2014) , 10.1016/J.BIOTECHADV.2014.02.004
Heidi R. Bokesch, Barry R. O'Keefe, Tawnya C. McKee, Lewis K. Pannell, Gregory M. L. Patterson, Roberta S. Gardella, Raymond C. Sowder, Jim Turpin, Karen Watson, Robert W. Buckheit,, Michael R. Boyd, A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium Scytonema varium† Biochemistry. ,vol. 42, pp. 2578- 2584 ,(2003) , 10.1021/BI0205698
Penelope Amelia Claire Sparrow, Judith A. Irwin, Phil J. Dale, Richard M. Twyman, Julian K. C. Ma, Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals Transgenic Research. ,vol. 16, pp. 147- 161 ,(2007) , 10.1007/S11248-007-9074-2
Andrew Hiatt, Robert Caffferkey, Katherine Bowdish, Production of antibodies in transgenic plants Nature. ,vol. 342, pp. 76- 78 ,(1989) , 10.1038/342076A0